Cells are the building blocks of life, and when living cells of a specific type are transplanted, they have the potential to treat or cure a wide variety of diseases and ailments. Current common cell therapies include bone marrow transplants and stem cell treatments.
The Kanslet™ transplantation system is a simple procedure that transplants engineered cell clusters via injection to free pets of a specific disease and improve the quality of life for them and their owners. Using its patented 3D micromold system, Likarda can produce scaffold-free, uniform cell clusters in a high efficiency and scalable manner. Many cells prefer to be in a three-dimensional format as they better mimic and maintain their natural function. These cell clusters can be made from most cell types. Likarda is interested in producing targeted cell therapies beyond its own internal pipeline.
Additionally, to make transplantation and the supply chain more scalable, Likarda is using its proprietary cryopreservation storage technique to create a first-of-its-kind companion animal tissue donation bank.